Skip to Main Content

What would you say if a cancer patient could be given a lower dose of a pricey treatment that was not only equally effective, but could also save a bundle of money?

That’s the proposition being advanced by some leading oncologists, who are promoting what they call value-based prescribing, which involves giving patients fewer or less frequent doses. The notion is being increasingly talked up as concerns mount over the rising cost of medicines and, consequently, the so-called financial toxicity that more patients are said to be experiencing.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

  • Refresher math — “…patients could take one pill each day instead of three and cut costs by one-third.” Actually, cutting two out of three (2/3) pills means that patients would be cutting costs by two-thirds (or, phrased somewhat more awkwardly, cutting costs *to* one third).

Comments are closed.